Abstract
Meningoencephalitis describes any process that results in the inflammation of both the meninges and the brain parenchyma. Underlying triggers for the development of meningoencephalitis can be infectious, autoimmune, vasculitic, neoplastic, or metabolic in origin. Patients who develop infectious meningoencephalitis typically present with fevers, headache, vomiting, nuchal rigidity, and signs of neurologic dysfunction, including altered mental status, seizures, or focal neurologic deficits. Pathogens that should be considered as potential causes of meningoencephalitis vary by patient risk factors, exposure history, and geographic location. Neurotropic viruses account for the vast majority of cases, some with clear geographic distributions (e.g., Japanese encephalitis virus) and others that are ubiquitous (e.g., herpes simplex viruses). A thorough history and physical examination can help to guide the diagnostic evaluation, although in many cases, the specific pathogen is never identified. Expert, supportive neurointensive care should be provided for all patients with meningoencephalitis. In addition, the parenteral administration of the antiviral medication, acyclovir, reduces the morbidity and mortality associated with herpes simplex virus meningoencephalitis when the infection is identified early and treatment initiated without delay. As such, intravenous acyclovir should be administered empirically to all patients with a clinical diagnosis of viral meningoencephalitis until infection with herpes simplex virus has been ruled out. Specific antimicrobial treatment for most other causes is not available.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Glaser CA, Honarmand S, Anderson LJ, Schnurr DP, Forghani B, Cossen CK, Schuster FL, Christie LJ, Tureen JH. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis. 2006;43:1565–77.
Calleri G, Libanore V, Corcione S, DeRosa FG, Caramello P. A retrospective study of viral central nervous system infections: relationship amongst aetiology, clinical course, and outcome. Infection. 2017;45:227–31.
Bookstaver PB, Mohorn PL, Shah A, Tesh LD, Quidley AM, Kothari R, Bland CM, Weissman S. Management of viral central nervous system infections: a primer for clinicians. J Cent Nerv Syst Dis. 2017;9:1179573517703342.
Kennedy PG, Quan PL, Lipkin WI. Viral encephalitis of unknown cause: current perspective and recent advances. Viruses. 2017;9:138.
Shahien R, Vieksler V, Bowirrat A. Amoxicillin-induced aseptic meningoencephalitis. Int J Gen Med. 2010;21:157–62.
Snell LB, Bakshi D. Neurological adverse effects of methylphenidate may be misdiagnosed as meningoencephalitis. BMJ Case Rep. 2015; https://doi.org/10.1136/bcr-2014-207796.
Hadley I, Jain R, Sreih A. Nonvasculitic autoimmune meningoencephalitis after rituximab: the potential downside of depleting regulatory B cells in the brain. J Clin Rheumatol. 2014;20:163–6.
Moreno-Ancillo A, Gil-Adrados AC, Jurado-Palomo J. Ibuprofen-induced aseptic meningoencephalitis confirmed by drug challenge. J Investig Allergol Clin Immunol. 2011;21:484–7.
Sonneville R, Klein I, de Broucker T, Wolff M. Post-infectious encephalitis in adults: diagnosis and management. J Infect. 2009;58:321–8.
Piantadosi A, Rubin DB, McQuillen DP, Hsu L, Lederer PA, Ashbaugh CD, Duffalo C, Duncan R, Thon J, Bhattacharyya S, Basgoz N, Feske SK, Lyons JL. Emerging cases of Powassan virus encephalitis in New England: clinical presentation, imaging, and review of the literature. Clin Infect Dis. 2016;62:707–13.
Yendell SJ, Fischer M, Staples JE. Colorado tick fever in the United States, 2002-2012. Vector Borne Zoonotic Dis. 2015;15:311–6.
Steffen R. Epidemiology of tick-borne encephalitis (TBE) in international travelers to Western/Central Europe and conclusions on vaccination recommendations. J Travel Med. 2016;23 https://doi.org/10.1093/jtm/taw018.
Bogovic P, Strle F. Tick-borne encephalitis: a review of epidemiology, clinical characteristics, and management. World J Clin Cases. 2015;3:430–41.
Halperin JJ. Neuroborreliosis. J Neurol. 2017;264:1292–7.
Chamizo FJ, Gilarranz R, Hernandez M, Ramos D, Pena MJ. Central nervous system infections caused by varicella-zoster virus. J Neurovirol. 2016;22:529–32.
Hong HL, Lee EM, Sung H, Kang JK, Lee SA, Choi SH. Clinical features, outcomes, and cerebrospinal fluid findings in adult patients with central nervous system (CNS) infections caused by varicella-zoster virus: comparison with enterovirus CNS infections. J Med Virol. 2014;86:2049–54.
Petersen LR, Brault AC, Nasci RS. West Nile virus: review of the literature. JAMA. 2013;310:308–15.
Kammer J, Ziesing S, Davila LA, Bultmann E, Illsinger S, Das AM, Haffner D, Hartmann H. Neurological manifestations of Mycoplasma pneumoniae infection in hospitalized children and their long-term follow-up. Neuropediatrics. 2016;47:308–17.
Jubelt B, Mihair C, Li TM, Verrapaneni P. Rhomboencephalitis/brainstem encephalitis. Curr Neurol Neurosci Rep. 2011;11:543–52.
Mazur-Melewska K, Brenska I, Jonczyk-Potoczna K, Kemnitz P, Pieczonka-Ruszkowska I, Mania A, Sluzewski W, Figlerowicz M. Neurologic complications caused by Epstein-Barr virus in pediatric patients. J Child Neurol. 2016;31:7010–8.
Modi S, Mahajan A, Dharaiya D, Varelas P, Mitsias P. Burden of herpes simplex virus encephalitis in the United States. J Neurol. 2017;264:1204–8.
Jones SC, Morris J, Hill G, Alderman M, St RRC. Lousi encephalitis outbreak in Louisiana in 2001. J La State Med Soc. 2002;154:303–6.
McJunkin JE, Khan RR, Tsai TF. California-La Crosse encephalitis. Infect Dis Clin N Am. 1998;12:83–93.
Yis U, Kurul SH, Cakmakci H, Dirik E. Mycoplasma pneumoniae: nervous system complications in childhood and review of the literature. Eur J Pediatr. 2008;167:973–8.
Pinninti SG, Kimberlin DW. Maternal and neonatal herpes simplex virus infections. Am J Perinatol. 2013;30:113–9.
Lin TY, Kao HT, Hsieh SH, Huang YC, Chiu CH, Chou YH, Yang PH, Lin RI, Tsao KC, Hsu KH, Chang LY. Neonatal enterovirus infections: emphasis on risk factors of severe and fatal infections. Pediatr Infect Dis J. 2003;22:889–94.
Davis J, Fairley D, Christie S, Coyle P, Tubman R, Shields MD. Human parechovirus infection in neonatal intensive care. Pediatr Infect Dis J. 2015;34:121–4.
Tunkel AR, Glaser CA, Bloch KC, Sejvar JJ, Marra CM, Roos KL, Hartman BJ, Kaplan SL, Scheld WM, Whitley RJ. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2008;47:303–27.
Britton PN, Eastwood K, Paterson B, Durrheim DN, Dale RC, Cheng AC, Kenedi C, Brew BJ, Burrow J, Nagree Y, Leman P, Smith DW, Read K, Booy R, Jones CA. Consensus guidelines for the investigation and management of encephalitis in adults and children in Australia and New Zealand. Intern Med J. 2015;45:563–76.
Steiner I, Budka H, Chaudhuri A, Koskiniemi M, Sainio K, Salonen O, Kennedy PGE. Viral meningoencephalitis: a review of diagnostics methods and guidelines for management. Eur J Neurol. 2010;17:999–e57.
Sili U, Kaya A, Mert A, HSV Encephalitis Study Group. Herpes simplex virus encephalitis: clinical manifestations, diagnosis, and outcome in 106 adult patients. J Clin Virol. 2014;60:112–8.
Granerod J, Ambrose HE, Davies NWS, Clewley JP, Walsh AL, Morgan D, Cunningham R, Zuckerman M, Mutton KJ, Solomon T, Ward KN, Lunn MPT, Irani SR, Vincent A, Brown DWG, Crowcroft NS. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis. 2010;10:835–44.
Kupila L, Vuorinen T, Vainionpaa R, Hukkanen V, Marttila RJ, Kotilainen P. Etiology of aseptic meningitis and encephalitis in an adult population. Neurology. 2006;66:75–80.
Singh TD, Fugate JE, Rabinstein AA. The spectrum of acute encephalitis. Neurology. 2015;84:359–66.
Glaser CA, Gilliam S, Schnurr D, Forghani B, Honarmand S, Khetsuriani N, Fischer M, Cossen CK, Anderson LJ. In search of encephalitis etiologies: diagnostic challenges in the California encephalitis project: 1998-2000. Clin Infect Dis. 2003;36:731–42.
Ascencao BB, Goncalves AC, Luis N, Sa J, Brito AP, Pocas JM. Epstein-Barr virus hemorrhagic meningoencephalitis: case report and review of the literature. J Neurovirol. 2016;22:695–8.
Morton NJ, Britton P, Palasanthiran P, Bye A, Sugo E, Kesson A, Ardern-Holmes S, Snelling TL. Severe hemorrhagic meningoencephalitis due to Angiostrongylus cantonensis among young children in Sydney, Australia. Clin Infect Dis. 2013;57:1158–61.
Martinez AJ, Visvesvara GS. Free-living amphizoic and opportunistic amebas. Brain Pathol. 1997;7:583–98.
Gavin PJ, Kazacos KR, Shulman ST. Baylisascariasis. Clin Microbiol Rev. 2005;18:703–18.
DeBiasi RL, Tyler KL. Molecular methods for diagnosis of viral encephalitis. Clin Microbiol Rev. 2004;17:903–25.
Steiner I, Schmutzhard E, Sellner J, Chaudhuri A, Kennedy PGE. EFNS-ENS guidelines for the use of PCR technology for the diagnosis of infections of the nervous system. Eur J Neurol. 2012;19:1278–97.
Huang C, Morse D, Slater B, Anand M, Tobin E, Smith P, Dupuis M, Hull R, Ferrera R, Rosen B, Grady L. Multiple-year experience in the diagnosis of viral central nervous system infections with a panel of polymerase chain reaction assays for detection of 11 viruses. Clin Infect Dis. 2004;39:630–5.
Studahl M, Bergstrom T, Hagberg L. Acute viral encephalitis in adults – a prospective study. Scand J Infect Dis. 1998;30:215–20.
Deresiewicz RL, Thaler SJ, Hsu L, Zamani AA. Clinical and neuroradiographic manifestations of eastern equine encephalitis. N Engl J Med. 1997;336:1867–74.
Riancho J, Delgado-Alvarado M, Sedano MJ, Polo JM, Berciano J. Herpes simplex encephalitis: clinical presentation, neurological sequelae, and new prognostics factors. Ten years of experience. Neurol Sci. 2013;34:1879–81.
Kaewpoowat Q, Salazar L, Aguilera E, Wootton SH, Hasbun R. Herpes simplex and varicella zoster CNS infections: clinical presentations, treatments, and outcomes. Infection. 2016;44:337–45.
George BP, Schneider EB, Venkatesan A. Encephalitis hospitalization rates and inpatient mortality in the United States, 2000-2010. PLoS One. 2014;9:e104169.
De Ory F, Avellon A, Echevarria JE, Sanchez-Seco MP, Trallero G, Cabrerizo M, Casas I, Pozo F, Fedele G, Vicente D, et al. Viral infections of the central nervous system in Spain: a prospective study. J Med Virol. 2013;85:554–62.
Kimberlin DW. Neonatal herpes simplex infection. Clin Microbiol Rev. 2004;17:1–13.
Bradshaw MJ, Venkatesan A. Herpes simplex virus-1 encephalitis in adults: pathophysiology, diagnosis, and management. Neurotherapeutics. 2016;13:493–508.
Cinque P, Cleator GM, Weber T, Monteyne P, Sindic CJ, van Loon AM. The role of laboratory investigation in the diagnosis and management of patients with suspected herpes simplex encephalitis: a consensus report. J Neurol Neurosurg Psychiatry. 1996;61:339–45.
Guffond T, Dewilde A, Lobert PE, Caparros-Lefebvre D, Hober D, Wattre P. Significance and clinical relevance of the detection of herpes simplex virus DNA by the polymerase chain reaction in cerebrospinal fluid from patients with presumed encephalitis. Clin Infect Dis. 1994;18:744–9.
Weil AA, Glaster CA, Amad Z, Forghani B. Patients with suspected herpes simplex encephalitis: rethinking an initial negative polymerase chain reaction result. Clin Infect Dis. 2002;34:1154–7.
Kimberlin DW, Whitley RJ, Wan W, Powell DA, Storch G, Ahmed A, et al. Oral acyclovir suppression and neurodevelopment after neonatal herpes. N Engl J Med. 2011;365:1284–92.
Gnann JW, Skolenberg B, Hart J, Aurelius E, Schliamser S, Studahl M, Eriksson BM, Hanley D, et al. Herpes simplex encephalitis: lack of clinical benefit of long-term valacylovir therapy. Clin Infect Dis. 2015;61:683–91.
Gershon AA, Breuer J, Cohen JI, Cohrs RJ, Gershon MD, Gilden D, Grose C, Hambleton S, Kennedy PG, Oxman MN, Seward JF, Yamanishi K. Varicella zoster virus infection. Nat Rev Dis Primers. 2015;1:15016.
De Broucker T, Mailles A, Chabrier S, Morand P, Stahl JP. Acute varicella zoster encephalitis without evidence of primary vasculopathy in a case-series of 20 patients. Clin Microbiol Infect. 2012;18:808–19.
Becerra JC, Sieber R, Martinetti G, Costa ST, Meylan P, Bernasconi E. Infection of the central nervous system caused by varicella zoster reactivation: a retrospective case series study. Int J Infect Dis. 2013;17:e529–34.
Wilson DA, Yen-Lieberman B, Schindler S, Asamoto K, Schold JD, Procop GW. Should varicella-zoster virus culture eliminated? A comparison of direct immunofluorescence antigen detection, culture, and PCR, with a historical review. J Clin Microbiol. 2012;50:4120–2.
Studahl M, Lindquist L, Eriksson BM, Gunther G, Bengner M, Franzen-Rohl E, Fohlman J, Bergstrom T, Aurelius E. Acute viral infections of the central nervous system in immunocompetent adults: diagnosis and management. Drugs. 2013;73:131–58.
Bathoorn E, Vlaminckx BJ, Schoondermark-Stolk S, Donders R, van der Meulen M, Thijsen SF. Primary Epstein-Barr virus infection with neurological complications. Scand J Infect Dis. 2011;43:136–44.
Belo F, Mendes I, Calha M, Mendonca C. Cytomegalovirus encephalitis in an immunocompetent child: a sceptic diagnosis. BMJ Case Rep. 2012; https://doi.org/10.1136/bcr-2012-006796.
Sadighi Z, Sabin ND, Hayden R, Stewart E, Pillai A. Diagnostic clues to human herpesvirus 6 encephalitis and Wernickie encephalopathy after pediatric hematopoietic cell transplantation. J Child Neurol. 2015;30:1307–14.
Yamamoto S, Takahashi S, Tanaka R, Okayama A, Araki A, Katano H, Tanaka-Taya K, Azuma H. Human herpesvirus-6 infection-associated acute encephalopathy without skin rash. Brain and Development. 2015;37:829–32.
Shahani L. HHV-6 encephalitis presenting as status epilepticus in an immunocompetent patient. BMJ Case Rep. 2014; https://doi.org/10.1136//bcr-20140295880.
Noguchi T, Yoshiura T, Hiwatashi A, Togao O, Yamashita K, Nagao E, Uchino A, Hasuo K, Atsumi K, Matsuura T, Kurolwa T, Mihara F, Honda H, Kudo S. CT and MRI findings of human herpesvirus 6-associated encephalopathy: comparison with findings of herpes simplex virus encephalitis. AJR Am J Roentoenol. 2010;194:754–60.
Provenzale JM, van Landingham K, White LE. Clinical and imaging findings suggesting human herpesvirus 6 encephalitis. Pediatr Neurol. 2010;42:32–9.
Guo Y, Wang S, Jiang B, Li J, Liu L, wang J, Zhao W, Jia J. Encephalitis with reversible splenial and deep cerebral white matter lesions associated with Epstein-Barr virus infection in adults. Neuropsychiatr Dis Treat. 2017;13:2085–92.
Zhang S, Feng J, Shi Y. Transient widespread cortical and splenial lesions in acute encephalitis/encephalopathy associated with primary Epstein-Barr virus infection. Int J Infect Dis. 2016;42:7–10.
Renard T, Daumas-Duport B, Auffray-Calvier E, Bourcier R, Desai H. Cytomegalovirus encephalitis: undescribed diffusion-weighted imaging characteristics. Original aspects of cases extracted from a retrospective study and from literature review. J Neuroradiol. 2016;43:371–7.
Maschke M, Kastrup O, Diener HC. CNS manifestations of cytomegalovirus infections: diagnosis and treatment. CNS Drugs. 2002;16:303–15.
Johnston WF, Yeh J, Nierenberg R, Procopio G. Exposure to macaque monkey bite. J Emerg Med. 2015;49:634–7.
De Crom SCM, Rossen JWA, van Furth AM, Obihara CC. Enterovirus and parechovirus infection in children: a brief overview. Eur J Pediatr. 2016;175:1023–9.
Dunn JJ. Enterovirus and parechovirus. Microbiol Spectr. 2016;4 https://doi.org/10.1128/microbiolspec.DMIH2-00006-2015.
Jain S, Patel B, Bhatt GC. Enteroviral encephalitis in children: clinical features, pathophysiology, and treatment advances. Pathog Glob Health. 2014;108:216–22.
Renaud C, Harrison CJ. Human parechovirus 3: the most common viral cause of meningoencephalitis in young infants. Infect Dis Clin N Am. 2015;29:415–28.
Shen WC, Chiu HH, Chow KC, Tsai CH. MR imaging findings of enteroviral encephalomyelitis: an outbreak in Taiwan. AJNR Am J Neuroradiol. 1999;20:1889–95.
Suthar MS. West Nile virus infection and immunity. Nat Rev Microbiol. 2013;11:115–28.
Montgomery RR, Murray KO. Risk factors for West Nile infection and disease in populations and individuals. Expert Rev Anti-Infect Ther. 2015;13:317–25.
Yeung MW, Shing E, Nelder M, Sander B. Epidemiologic and clinical parameters of West Nile virus infections in humans: a scoping review. BMC Infect Dis. 2017;17:609.
Nett RJ, Kuehnert MJ, Ison MG, Orlowski JP, Fischer M, Staples JE. Current practices and evaluation of screening solid organ donors for West Nile virus. Transpl Infect Dis. 2012;14:268–77.
Mezochow AK, Henry R, Blumberg EA, Kotton CN. Transfusion transmitted infections in solid organ transplantation. Am J Transplant. 2015;15:547–54.
Seivar JJ, Haddad MB, Tierney BC, Campbell GL, Marfin AA, Van Gerpen JA, Fleischauer A, Leis AA, Stokic DS, Petersen LR. Neurologic manifestations and outcome of West Nile virus infection. JAMA. 2003;290:511–5.
Davis LE, Beckham JD, Tyler KL. North American encephalitic arboviruses. Neurol Clin. 2008;26:727.
Gaensbauer JT, Lindsey NP, Messacar K, Staples JE, Fischer M. Neuroinvasive arboviral disease in the United States: 2003 to 2012. Pediatrics. 2014;134:e642.
Marfin AA, Bleed DM, Lofgren JP, Olin AC, Savage HM, Smith GC, Moore PS, Karabatsos N, Tsai TF. Epidemiologic aspects of a St. Louis encephalitis epidemic in Jefferson County Arkansas, 1991. Am J Trop Med Hyg. 1993;49:30–7.
Calisher CH. Medically important arboviruses of the United States and Canada. Clin Microbiol Rev. 1994;7:89–116.
Rahal JJ, Anderson J, Rosenberg C, Reagan T, Thompson LL. Effect of interferon-alpha2b therapy on St. Louis viral meningoencephalitis: clinical and laboratory results of a pilot study. J Infect Dis. 2004;190:1084–7.
McJunkin JE, de los Reyes EC, Irazuzta JE, Caceres MJ, Khan RR, Minnich LL, Fu KD, Lovett GD, Tsai T, Thompson A. La Crosse encephalitis in children. N Engl J Med. 2001;344:801–7.
Miller A, Carchman R, Long R, Denslow SA. La Crosse viral infection in hospitalized pediatric patients in Western North Carolina. Hosp Pediatr. 2012;2:235–42.
Yousaf MZ, Qasim M, Zia S, Khan MR, Ashfaq UA, Khan S. Rabies molecular virology, diagnosis, prevention and treatment. Virol J. 2012;9:50.
Maier T, Schwarting A, Mauer D, Ros RS, Martens A, Kliem V, Wahl J, Panning M, Baumgarte S, Muller T, Pfefferle S, Ebel H, Schmidt J, Tenner-Racz K, Racz P, et al. Management and outcomes after multiple corneal and solid organ transplantations from a donor infected with rabies virus. Clin Infect Dis. 2010;50:1112.
Dimaano EM, Scholand SJ, Alera MP, Belandres DB. Clinical and epidemiological features of human rabies cases in the Philippines: a review from 1987 to 2006. Int J Infect Dis. 2011;15:e495–9.
Christie LJ, Honarmand S, Talkington DF, Gavali SS, Preas C, Pan CY, Yagi S, Glaser CA. Pediatric encephalitis: what is the role of Mycoplasma pneumoniae? Pediatrics. 2007;120:305–13.
Cope JR, Ali IK. Primary amebic meningoencephalitis: what have we learned in the last five years? Curr Infect Dis Rep. 2016;18:31.
Krol-Turminska K, Olender A. Human infections caused by free-living amoebae. Ann Agric Environ Med. 2017;24:254–60.
Gnann JW, Whitley RJ. Herpes simplex encephalitis: an update. Curr Infect Dis Rep. 2017;19:13.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Suryadevara, M. (2019). Meningoencephalitis. In: Domachowske, J. (eds) Introduction to Clinical Infectious Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-91080-2_25
Download citation
DOI: https://doi.org/10.1007/978-3-319-91080-2_25
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-91079-6
Online ISBN: 978-3-319-91080-2
eBook Packages: MedicineMedicine (R0)